Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

KPTI Karyopharm Therapeutics Inc.
$5.40 -1.37% -0.08
Notify me if price changes either direction
Interactive Brokers Logotype

Buy KPTI stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 107.5M
Enterprise value 342.7M
Trailing PE -0.30117122141662
Forward PE -2.1832669
PEG Ratio -0.005138466336966
Enterprise to EBITDA -3.791
Enterprise to revenue 2.346
Price to book MRQ -0.3300546895803
Price to sales TTM 0.84575826

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 146.1M
EBITDA -90411000
Diluted EPS TTM -17.93
Total Cash (MRQ) 63.7M
Current ratio (MRQ) 1.12
Operating Cash Flow (TTM) -75369000

KPTI trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent KPTI News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.